Figure 1B Amplitude of low frequency fluctuation  (ALFF) differences between ALS and control groups without grey matter (GM) correction (A) and with GM correction (B).
Image credit: Luo, et.al. 2012 under CC BY license

Meeting Calendar

Newly Added:

Congress of the European Academy of Neurology
Amsterdam, Netherlands
June 24-27, 2017




2017


May 2017


Phase Transitions in Biology and Disease
Description: In the past few years the concept of protein phase transitions has taken the field of cell biology and protein biochemistry by storm. The initial discoveries were met with great enthusiasm as they provide the rationale for the formation of membrane-less organelles, such as stress granules, processing bodies and RNP bodies, in biology and human disease. By studying the biophysics of the involved proteins, it was shown that this process could be modeled by liquid-liquid demixing, also making the connection of such liquid compartments to characteristic protein aggregations observed in numerous neurodegenerative diseases. Whereas this is perhaps one of the biggest breakthroughs in these fields in recent years, key questions remain to be addressed towards the goal of fully understanding their functional properties in the cell and targeting them in proteinopathies. This meeting gathers leading figures from the phase transition and protein aggregation field, whose work has spearheaded the recent developments. Where have we come from? Where are we now? And moreover, which direction the field is heading?
Location: Leuven, Belgium
Date: May 2-3, 2017
Abstracts Due: March 21, 2017

Venusberg Meeting on Neuroinflammation
Sponsor: The German Center for Neurological Diseases (DZNE)
Description: This year, for the 5th annual meeting, we intend to cover a wide range of different aspects of immune activation in the brain. We have composed sessions that focus on new genetic hints, the role of the microbiome for CNS function and neuron-glia interactions. Renowned speakers will cover neuroinflammation topics and connect their recent findings and insights to clinical observations and development of novel treatment strategies. Registration deadline: March 15, 2017.
Location: Bonn, Germany
Date: May 11-13, 2017

ENCALS 2017
Sponsor: European Network for the Cure of ALS (ENCALS )
Description: The meeting is the annual meeting of the European Network to Cure ALS (ENCALS).
Location: Ljubljana, Slovenia
Date: May 18-20, 2017
Abstracts Due: March 20, 2017

Annual World Congress on NeuroTalk
Description: The theme for Neurotalk-2017 will be "New Technologies, New Ideas and New Future". The Annual World Congress of Neurotalk (NT) series contributes to offering professionals in the field of Neuroscience a multidisciplinary informative cooperative platform.
Location: Barcelona, Spain
Date: May 22-24, 2017
Abstracts Due: March 31, 2017

June 2017


EMBO-EMBL Symposium on Mechanisms of Neurodegeneration
Description: This symposium will focus on the molecular basis of major neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, with a strong emphasis on mechanism based drug development. The meeting will cover the various molecular mechanisms linked to these diseases, including RNA biology, nuclear transport, protein processing, protein aggregation and protein folding. The symposium will also address the genetic components underlying neurodegeneration and the involvement of innate immune responses, discuss disease biomarkers and therapeutic options, as well as using animal models for studying neurodegenerative disease.
Location: Heidelberg, Germany
Date: June 14-17, 2017
Abstracts Due: April 3, 2017

Keystone Symposium on Neuroinflammation
Sponsor: Keystone Symposia
Description: This meeting will integrate “immune” elements of the CNS (microglia, complement, certain chemokines) into a broader scheme of neurodevelopment and indicate where aberrant function of these elements might conduce to neurodevelopmental disorders such as autism. The meeting will also characterize the neuroinflammatory processes which typify aging and integrate this temporal dynamic into the pathogenesis of neurodegenerative disease and highlight model systems and technical innovations which can be particularly powerful for generating mechanistic insights into neuroinflammatory processes.
Location: Keystone, Colorado
Date: June 19-23, 2017
Abstracts Due: March 21, 2017

NEW! Congress of the European Academy of Neurology
Description: This is the 3rd Congress of the European Academy of Neurology. Scientific symposia include ALS and FTD. Late breaking abstracts are still being accepted. Registration deadline: May 5.
Location: Amsterdam, Netherlands
Date: June 24-27, 2017

Meeting the Challenges of Modelling Neurodegenerative Disease in Mice
Sponsor: The Royal Society
Description: New technologies for engineering the mouse genome are increasingly sophisticated. However, mouse models of neurodegeneration try to recapitulate human late-onset disorders in an animal that lives for two years and has important differences in physiology and biochemistry. How can we best model neurodegeneration? What features matter? What has given us most insight? What is the future we would like?
Location: Buckinghamshire, England
Date: June 26-27, 2017

July 2017


European Meeting on Glial Cells in Health and Disease
Sponsor: Network Glia
Description: The XIII European Meeting on Glial Cells in Health and Disease invites participation from neuroglia researchers from all over the world to Edinburgh. More than 20 years after being established by an inaugural meeting in Heidelberg, the European Glial meeting has become the world’s largest and most comprehensive scientific gathering on glial cell biology and medicine. After the success of the 2015 meeting in Bilbao, the conference comes to Edinburgh, the city where the Scottish pathologist W. Ford Robertson first recognised the oligodendrocyte in 1899. Here, it will be hosted by the vibrant glial research community based in Scotland whose internationally-leading work encompasses the full range of fundamental and translational glial neuroscience.
Location: Edinburgh, Scotland
Date: July 8-11, 2017
Abstracts Due: February 1, 2017

Gordon Research Conference on Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases
Sponsor: Gordon Research Conferences
Description: The goal of this meeting is to provide a dynamic forum for the active exchange of new discoveries and research tools in the advancing field of motor neuron diseases. The conference will bring together experts in a wide range of basic, clinical and translational neuroscience to discuss advances in the progress of understanding common and rare motor neuron diseases. Exciting new areas of research in these disease include dysfunction in RNA metabolism and protein homeostasis, with specific defects in nucleocytoplasmic trafficking, induction of endoplasmic reticulum stress, and impaired dynamics of ribonucleoprotein bodies such as RNA granules. In addition, the use and validation of imaging modalities, such as PET, as well as large population multi-omics data generation, to identify and validate dysfunctional pathways in animal models and patients, as well as the development of new therapies and biomarkers will be discussed. Applications for this meeting must be submitted by June 25, 2017, but please apply early, as some meetings become oversubscribed (full) before this deadline. Preliminary program will be available by November 15, 2016 - please check the conference's website for updates.  
Location: Stoweflake Conference Center, Stowe, VT, USA
Date: July 23-28, 2017
Abstracts Due: June 25, 2017

September 2017


4th Ottawa International Conference on Neuromuscular Disease and Biology
Sponsor: University of Ottawa - Centre for Neuromuscular Disease
Description: The Conference is structured for both basic researchers and clinicians and will feature internationally-recognized invited speakers highlighting advances in all aspects of NMD research, including novel techniques to diagnose NMD, biology of disease pathogenesis, expanding clinical phenotypes, basic muscle and stem cell biology, and promising therapies to treat these devastating disorders. Registration will open Spring 2017.
Location: Ottawa, Ontario, Canada
Date: September 7-9, 2017

World Congress of Neurology 2017
Sponsor: World Federation of Neurology (WFN)
Description: More details available soon!
Location: Kyoto, Japan
Date: September 16-21, 2017

Neuro-Immune Axis. Reciprocal Regulation in Development, Health and Disease.
Sponsor: Cell Press
Description: The goal of this symposium is to explore the interface between the nervous and immune systems during development, homeostasis, and disease. The meeting will examine the mediators, mechanisms, and implications of neuro-immune crosstalk in the central and peripheral nervous systems. It will also cover emerging areas such as the neuronal regulation of peripheral immune function and the influence of the microbiota on the brain. We will bring together researchers from across the fields of neuroscience and immunology to facilitate discussion of exciting new concepts and developments in both fields.
Location: Sitges, Spain
Date: September 17-19, 2017
Abstracts Due: June 09, 2017

November 2017


Society for Neuroscience Annual Meeting
Description: The Society for Neuroscience (SFN)'s 47th annual meeting is the premier venue for neuroscientists to present emerging science, learn from experts, collaborate with peers, explore new tools and technologies, and advance careers.
Location: Washington, DC
Date: November 11-15, 2017
Abstracts Due: May 6, 2017

December 2017


ALS/MND Allied Professionals Forum
Description: The Allied Professionals Forum is focused on practice and experience for health professionals in the care and support of people living with ALS/MND. During the APF, health professionals from around the globe come together to share their practical knowledge and experiences, with a mission to improve the quality of care for people living with ALS/MND worldwide.
Location: Boston, MA
Date: December 7, 2017

International Symposium on ALS/MND
Sponsor: ALS TDI and The ALS Hope Foundation
Description: The International Symposium on ALS/MND is a unique annual event which brings together leading international researchers as well as health and social care professionals to present and debate key innovations in their respective fields. The Symposium is planned as two parallel meetings, one on biomedical science and the other on research and advances in the care and management of people affected by ALS/MND. Joint sessions consider issues of mutual concern, challenging current views and practice.
Location: Boston, MA
Date: December 8-10, 2017
Abstracts Due: May 26, 2017


Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail